[The phenomenon of proteolytic activation of myxoviruses and a new strategy for treating viral diseases].
D000818:Animals; D004353:Drug Evaluation, Preclinical; D004347:Drug Interactions; D006023:Glycoproteins / Q000378:metabolism; D006389:Hemagglutinins, Viral; D006801:Humans; D009439:Neuraminidase / Q000378:metabolism; D009975:Orthomyxoviridae / Q000254:growth & development* / Q000378:metabolism / Q000472:pathogenicity; D009976:Orthomyxoviridae Infections / Q000188:drug therapy / Q000382:microbiology*; D010447:Peptide Hydrolases / Q000378:metabolism*; D011480:Protease Inhibitors / Q000627:therapeutic use*; D014764:Viral Proteins / Q000378:metabolism; D014766:Viremia / Q000188:drug therapy / Q000382:microbiology; D014771:Virion / Q000187:drug effects / Q000378:metabolism; D014774:Virulence / Q000187:drug effects; D014775:Virus Activation / Q000187:drug effects*; D014779:Virus Replication / Q000187:drug effects
D006023:Glycoproteins; D006389:Hemagglutinins, Viral; D011480:Protease Inhibitors; D014764:Viral Proteins; D009439:Neuraminidase; D010447:Peptide Hydrolases
Fenomen proteoliticheskoĭ aktivatsii miksovirusov i novaia strategiia lecheniia virusnykh zabolevaniĭ.